InvestorsHub Logo
Followers 375
Posts 16963
Boards Moderated 4
Alias Born 03/07/2014

Re: Gsdubb post# 7698

Sunday, 04/20/2014 11:55:21 AM

Sunday, April 20, 2014 11:55:21 AM

Post# of 106837
I guess that's probably it? Does the 170 number "jive" with what would be "Marvel part 2"? I don't remember- w/o going to 10-K and searching for it? Maybe it should be updated - cause some are going to see Feb. 2014, "final data" for a big number like 170 enrolled/patients and probably think something pretty big is cooking, IMO.

Also, it'd sure help IMO if they'd just put "Marvel" or whatever right on the .gov site. I noticed (and it's just a random sample, cause I happened to have read it), that Baxter for example put the trial "name" ( I think it's "RENEW" or something like that)right in the .gov site listing.

Thus, when there are all these "named" trials, across lots of dates/yrs, time periods- it's sure a lot easier to keep them sorted out.

You got the Apple trial, the Orange trial, the Peach trial, etc. Then when you see the "Autologous xyx, inhibitory, super duper, dna suppressant, cardiac blah, blah" in the header- you have no idea what that trial is often, but if you saw the "Orange" trial as a sub title, then one can say, bingo, I know that's the same on from 10-K page such and such, or that was the "Orange trial" that was in PR XYZ last month.

Just makes it easier IMO. Some companies use fruit names, or some other common object. BHRT looks like they use nice sounding names (nothing wrong with that- it's a way to make it easily remembered in PR and so forth) like "MARVEL" or "MIRROR" or "REGEN" (obviously a take-off of "regenerative" and that's all cool).

Would be easier to "sort" if those names are always attached to the trial's "formal title" which is usually long and very "medical terminology" based.

Just an opinion. No biggie.